← Back to Search

Device

Participants with ongoing non-convulsive or focal motor SE for Seizures

N/A

Waitlist Available

Led By David King-Stephens, MD

Research Sponsored by Yale University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline and 10 minutes

Awards & highlights

Study Summary

This trial studies a new treatment to reduce seizure activity in patients with Non-Convulsive or Focal Motor Status Epilepticus. It uses ultrasound to target brain areas.

Eligible Conditions

Seizures

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline and 10 minutes

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline and 10 minutes

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 10 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in epileptiform activity

Trial Design

1Treatment groups

Experimental Treatment

Group I: Participants with ongoing non-convulsive or focal motor SEExperimental Treatment1 Intervention

Adult patients with ongoing non-convulsive or focal motor SE despite treatment with at least 2 ASMs and who are monitored with surface EEG will be screened and enrolled to receive up to 2 sessions of PLIFU.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Swebilius FoundationUNKNOWN

Yale UniversityLead Sponsor

1,847 Previous Clinical Trials

2,736,518 Total Patients Enrolled

3 Trials studying Seizures

8,308 Patients Enrolled for Seizures

David King-Stephens, MDPrincipal InvestigatorYale University

1 Previous Clinical Trials

240 Total Patients Enrolled

Media Library

PLIFU (Device) Clinical Trial Eligibility Overview. Trial Name: NCT05784805 — N/A

Seizures Research Study Groups: Participants with ongoing non-convulsive or focal motor SE

Seizures Clinical Trial 2023: PLIFU Highlights & Side Effects. Trial Name: NCT05784805 — N/A

PLIFU (Device) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05784805 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research initiative open to participants over the age of 80?

"According to the parameters of this clinical trial, suitable participants must fall within 19 and 85 years of age. There are 50 spots available for those under 18 while 75 slots are open to individuals aged 65 or above."

Answered by AI

What criteria make someone a suitable participant for this research?

"Eligible participants must have a history of seizures and lie within the age bracket between 19-85. 10 patients are currently being sought for this clinical trial."

Answered by AI

What is the current status of recruitment for this trial?

"According to clinicaltrials.gov, this medical investigation is not currently recruiting patients despite being first posted on April 1st 2023 and most recently updated March 13th of the same year. Fortunately, there are 109 other trials that are actively looking for participants right now."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Acute Effects of Focused Ultrasound Modulation on EEG Behavior in Status Epilepticus Patients

2023. "Acute Effects of Focused Ultrasound Modulation on EEG Behavior in Status Epilepticus Patients". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05784805.